No clinically relevant drug–drug interactions when dalcetrapib is co-administered with atorvastatin

Author： Derks Michael Abt Markus Parr Graeme Meneses-Lorente Georgina Young Anne-Marie Phelan Mary

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.10, 2010-10, pp. : 1135-1145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinically relevant drug–drug interactions between antiretrovirals and antifungals

By Vadlapatla Ramya Krishna Patel Mitesh Paturi Durga K Pal Dhananjay Mitra Ashim K

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 4, 2014-04 ,pp. : 561-580

Informa Healthcare

Access to resources Recommend Favorite

Mechanisms of Clinically Relevant Drug Interactions Associated with Tacrolimus

By Christians U.

Clinical Pharmacokinetics, Vol. 41, Iss. 11, 2002-01 ,pp. : 813-851

Adis International

Access to resources Recommend Favorite

Clinically Relevant Pharmacokinetic Herb-drug Interactions in Antiretroviral Therapy

Current Drug Metabolism, Vol. 17, Iss. 1, 2016-01 ,pp. : 52-64

Bentham Science Publishers

Access to resources Recommend Favorite

Predictions of Metabolic Drug-Drug Interactions Using Physiologically Based Modelling: Two Cytochrome P450 3A4 Substrates Coadministered with Ketoconazole or Verapamil

By Perdaems Nathalie

Clinical Pharmacokinetics, Vol. 49, Iss. 4, 2010-04 ,pp. : 239-258

Adis International

Access to resources Recommend Favorite

Chronopharmaceutics: As a clinically relevant drug delivery system

By Gandhi B. R. Mundada A. S. Gandhi P. P.

Drug Delivery, Vol. 18, Iss. 1, 2011-01 ,pp. : 1-18

Informa Healthcare

Access to resources Recommend Favorite